概要

DIA is proud to present a dedicated event that focuses on the integration of project/portfolio management and research and development in the healthcare setting that is objective and driven by practitioners, for practitioners. This conference is tailored for project managers in healthcare product development to provide relevant information to be successful given the current climate. Project managers working in all stages of the healthcare product lifecycle will share their perspectives on managing projects during a pandemic and utilizing lessons learned for resource planning, opportunity costs, and trade-offs. Other discussions will be centered on building resiliency in the workplace, understanding and learning from failures in drug development, and appreciating and utilizing diverse leadership styles to drive projects forward.

The Impact of Project Management in Healthcare Product Development meeting is a neutral platform for project and portfolio knowledge sharing related to healthcare research and development. This meeting will provide an in-depth contemplation of topics specific to healthcare product development and project management needs.

Featured

Want to learn more about The Impact of Project Management in Healthcare Product Development? You've come to the right site!

参加対象

Professionals and students from industry, academia, and government involved in all phases of the healthcare product lifecycle who are interested in applying new skills and tools to improve program and project execution including:

Global Project Management and Leadership
Portfolio and Alliance Management
Functional Leaders and team members
Clinical Operations
Regulatory Affairs Professionals
Clinical Development
CMC

学習目的

At the conclusion of this activity, participants should be able to:

Discuss the important role that project managers play in managing complexity and enabling execution in healthcare product development
Describe how COVID-19 changed project management for vaccine, therapeutic, and diagnostic development
Identify methods of adaptation and lessons learned from managing projects during the COVID-19 pandemic and apply best practices as new standards for healthcare product development
Apply methodologies and technologies to enhance project planning, learn from past experiences, and effectively lead and collaborate on projects
Describe the adaptations and methods that project managers used during the pandemic to deliver vaccines, therapeutics, and diagnostics under stress and accelerated timelines

プログラム委員会

Karla Childers, MS Head, Bioethics-Based Science and Technology Policy
Johnson & Johnson, United States
Nita Ichhpurani, PMP Consultant To Daiichi Sankyo, Inc.
Phase One Forward, Consultant, Canada
Mark Kryah, PMP Executive Director, Program Team Leader, Program and Portfolio Management
Ultragenyx Pharmaceutical Inc., United States
Leigh Shultz, PhD, PMP Executive Director, Human Health Commercial Operations
Merck & Co., Inc., United States
Elizabeth Somers, MS Executive Director, Global Project and Alliance Management
Merck Sharp & Dohme LLC, United States